Laboratory Health & Safety — Questions

Universal precautions govern the response: the sample is treated as infectious throughout, and the sequence is deliberate rather than hurried.

• Evacuate and warn: clear people from the immediate area and alert nearby staff.
• Allow aerosols to settle: do not rush back in; wait for airborne particles to disperse, longer where there is no central exhaust.
• Assess exposure and notify: refer anyone splashed or otherwise exposed for medical evaluation, and inform the supervisor and biosafety officer.
• Decontaminate in PPE: wearing personal protective equipment (PPE), meaning gloves, a gown and eye protection, cover the spill with absorbent material and apply a suitable disinfectant working from the outside inward.
• Contact time and clear-up: leave the disinfectant for its full contact time, then remove the material, wipe the surface again, and discard everything as infectious waste.

Triple packaging protects handlers and the environment through three layers:

• Primary receptacle: the sealed, leak-proof specimen tube, wrapped in enough absorbent material to soak up the entire contents if it breaks.
• Secondary packaging: a durable, leak-proof, sealed container enclosing the primary receptacle.
• Outer packaging: a rigid shipping container of adequate strength, bearing the biohazard and Category A labelling.

For a suspected VHF specimen the system is classified Category A, UN2814, under International Air Transport Association (IATA) packing instruction 620, kept cold and moved only by prior arrangement.

a. Primary purpose. A Class II biological safety cabinet contains infectious aerosols and gives three-way protection: it shields the operator and the environment while also protecting the specimen from contamination.

b. Airflow principles. Inward air at the front aperture carries aerosols away from the operator; a curtain of high-efficiency particulate air (HEPA) filtered air flowing downward protects the work surface; and HEPA-filtered exhaust protects the environment before air is recirculated or ducted away.

c. Limitation. A Class II Type A cabinet is not a chemical fume hood and does not clear volatile chemicals; its protection is also easily degraded by draughts, rapid arm movements or poor positioning, so it never replaces good microbiological technique.

A complete answer explains that essential tests are still done, but under precautions, and that Ebola confirmation is handled separately.

Do the essential tests. Life-saving and monitoring tests (full blood count, malaria smear, coagulation, urea and electrolytes, liver function, cross-match) are performed on site and never withheld while viral haemorrhagic fever (VHF) is being considered.

Under enhanced precautions. A small team of experienced staff works in a demarcated area; any aerosol-generating or open step is done inside a biosafety cabinet under enhanced protective equipment; closed automated systems are used where possible; and waste is handled as high-risk.

Inactivation and closed systems. Where possible, samples are chemically inactivated before analysis, and closed analysers reduce exposure.

Ebola confirmation is separate. The Ebola test itself is not done in the routine laboratory: a specimen is sent, after prior consultation and under Category A packaging, to the reference laboratory. The routine samples are traced and treated as potentially infectious, and destroyed only after consulting the reference laboratory.

A complete answer covers what makes one molecular assay better than another, then how that claim is checked first from documentation and then on local samples.

Characteristics of a superior assay

• Higher analytical sensitivity (a lower limit of detection), which matters greatly in cerebrospinal fluid where viral loads are low.
• High specificity with detection and typing of both HSV-1 and HSV-2, ideally as part of a syndromic multiplex panel.
• Built-in controls: an internal extraction and amplification control to flag inhibition or failed extraction.
• Validated across the required specimen types (cerebrospinal fluid, genital and mucocutaneous swabs, blood) and robust to inhibitors such as blood in cerebrospinal fluid.
• Operational advantages: faster turnaround, automation, higher throughput, lower cost per test, and ease of use.

Evaluation on paper

• Review the manufacturer’s validation data, regulatory approvals and independent peer-reviewed evaluations.
• Examine the stated limit of detection, analytical sensitivity and specificity, linearity, reproducibility and cross-reactivity, and compare them against the current assay.

Evaluation in practice

• Method comparison against the current assay or reference standard on local samples, reporting concordance, sensitivity, specificity and an agreement statistic such as Cohen’s kappa.
• Verify the limit of detection with dilution panels, and assess precision within and between runs.
• Run external quality assessment and proficiency panels.
• Assess the practical fit: workflow, turnaround, cost, training needs and likely clinical impact.

Decision

The new assay is adopted if it improves sensitivity, specificity, turnaround or cost without loss of accuracy, and is then kept under ongoing internal quality control and external quality assessment.

A high-efficiency particulate air (HEPA) filter removes at least 99.97% of particles at 0.3 micrometres, the most penetrating particle size, and captures larger and smaller particles even more efficiently.

It does not remove gases or vapours, and it captures viral-sized particles, not only bacteria.

A routine diagnostic specimen for HIV testing travels as Category B under UN3373, “Biological substance, Category B”, packed to packing instruction P650.

Category A (UN2814) is reserved for cultures and the most dangerous agents, UN2900 applies to animal-only pathogens, and the specimen is neither exempt nor unregulated.

A suspected VHF specimen is a Category A infectious substance, shipped under UN2814 with International Air Transport Association (IATA) packing instruction 620.

Routine diagnostic samples are the lower Category B (UN3373); the exempt, non-hazardous and Category C options do not apply.

A Class II Type A cabinet recirculates most of its air after high-efficiency particulate air (HEPA) filtration, and HEPA does not trap chemical vapour, so flammable or toxic volatiles build up and are returned to the room. Such work needs a fume hood or a total-exhaust cabinet.

A Class II cabinet does protect the operator, does carry HEPA filters, and is not restricted to one risk group.

Contaminated sharps go directly into a puncture-resistant container and are treated as infectious waste, never recapped, reused or landfilled untreated. Needles are not re-covered by hand, which is a leading cause of needlestick injury.

Bagging with general waste, recapping, recycling or flushing all risk injury or release.

PPE sits at the bottom of the hierarchy of controls: it protects only the wearer, and only when correctly used, so it is applied after elimination, engineering and administrative controls, not instead of them.

Treating PPE as the first or sole control, or as better than removing the hazard, inverts the hierarchy.

The itemised list of contents is placed between the secondary packaging and the rigid outer packaging, where it stays legible and protected yet clear of any leak from the primary receptacle. Absorbent material, by contrast, is wrapped around the primary receptacle to soak up a spill.

Placing the list with the specimen, hiding it inside the primary, or omitting it would breach the packaging rules.

When classification is uncertain, the employer performs a risk assessment and provisionally assigns the higher of the groups in question, then notifies the chief inspector. Any human virus not yet assessed defaults to at least group 2.

Defaulting to group 1, assuming harmlessness, or classifying by volume would all understate the hazard.

Universal precautions treat all blood and specified body fluids as though infectious for bloodborne viruses such as HIV and hepatitis B, regardless of the known or suspected diagnosis. Standard precautions extend the same logic to all body fluids, non-intact skin and mucous membranes.

Selective care based on known status, or substituting gloves for hand hygiene, defeats the purpose.

The defining features of a group 4 agent are ready person-to-person transmission and the absence of effective prophylaxis or treatment, which together justify maximum containment. A group 3 agent may cause severe disease but spreads less readily and has available countermeasures.

Size, host range and severity alone do not set the group, and no group 4 agent is worked on the open bench.

A biological indicator, spores of Geobacillus stearothermophilus, is the test that proves sterilisation, because it confirms the cycle killed a highly heat-resistant organism.

Autoclave tape, pressure and run time show only that a load was processed, not that it was rendered safe.

Marburg virus is a risk group 4 agent: it causes severe viral haemorrhagic fever, transmits readily from person to person, and has no established curative treatment or licensed vaccine.

Hepatitis B, cytomegalovirus, respiratory syncytial virus and rotavirus are handled at lower containment as risk group 2 agents.

A Class I cabinet draws room air inward across the work and exhausts it through a high-efficiency particulate air (HEPA) filter, protecting the operator and environment but not the specimen, because unfiltered room air passes over the work surface.

Product protection is the Class II feature, and the sealed-glovebox description belongs to Class III.

Real risk is the agent plus the procedure, the operator’s competence and the environment, so the same virus can be safe in a sealed molecular assay yet hazardous in open high-volume culture. This is why the modern framework matches containment through a risk assessment rather than mapping risk group straight to biosafety level.

The other options misstate how risk grouping and containment relate.